The Report Guru

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2026. Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period. The global immunohistochemistry market is highly competitive. Prominent players operating in the global immunohistochemistry market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product launches and approvals to expand their product and geographic footprint and incr

The oral care market is expected to see a significant increase in value over the next few years, with a projected growth from USD 47.2 billion in 2021 to USD 54.9 billion in 2026, at a CAGR of 3.1%. The growth of this market can be attributed to various factors, such as the rising incidence of dental diseases, an increasing number of practicing dentists globally, and technological advancements in oral care products. However, the oral care market also faces some challenges. For instance, product recalls have the potential to restrain the growth of the market, while the adverse effects of teeth whitening products pose a significant challenge. The market is highly consolidated, with major players such as Colgate-Palmolive Company, Procter Gamble, GlaxoSmithKline plc, Koninklijke Philips N.V., Johnson Johnson, and Unilever plc dominating the market. These players have adopted various strategies such as acquisitions, partnerships, agreements, collaborations, expansions, and

The global in vitro toxicology testing market is set to experience significant growth, with the market projected to reach USD 18.6 billion by 2027 from USD 11.2 billion in 2022, growing at a CAGR of 10.8%. The key drivers of this growth include increasing R&D expenditure to detect toxicity at an early stage during drug development, as well as the pharmaceutical and cosmetics industries' increasing focus on using in vitro methods. This market is highly competitive, with key players such as Thermo Fisher Scientific, Merck KGaA, and Laboratory Corporation of America Holdings focusing on increasing their presence in high-growth markets through organic and inorganic growth strategies. Thermo Fisher Scientific is a leading player in the in vitro toxicology testing market, providing laboratory equipment, analytical instruments, consumables, services, and reagents. With a strong global sales and distribution network, the company operates from the Life Science Business se

Defibrillators have become an essential tool for healthcare professionals in the treatment of life-threatening cardiac arrhythmias. As the demand for defibrillators continues to rise, it's important to examine the key players that are shaping the industry. The global defibrillator market is expected to reach USD 18.2 billion by 2026 from an estimated USD 11.4 billion in 2021, at a CAGR of 9.7% from 2021 to 2026. The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2018–2020 to expand their global presence and increase their market shares in the defibrillator market. The key growth strategies adopted by the top players in the market include product launches & approvals, mergers & acquisitions, collaborations, partnerships, and agreements. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market. The defibr

The global hyperspectral imaging system market is projected to reach USD 34.3  billion by 2028 from USD 16.8 billion in 2023, at a CAGR of 15.4% during the forecast period. Growing funds and related investments and the untapped opportunities in emerging markets are expected to provide growth opportunities for players during the forecast period. The hyperspectral imaging system market is highly fragmented and is dominated by various players. The major players operating in this market are Headwall Photonics (the US), Corning Incorporated (US), Specim, Spectral Imaging Ltd. (Finland), Resonon, Inc. (US), and Norsk Elektro Optikk (Norway). These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities to further expand their presence in the hyperspectral imaging system market. To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24697

The global optical imaging market is projected to reach USD 2.9 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.5%. Precise differentiation between soft tissues and affected tissues, reduced patient exposure to eradicating radiations, increased prevalence of age related macular degeneration, increased GDP expenditure on healthcare among rapidly growing economies, increased need and adoption of non invasive tools for rapid scanning and identification of disorders coupled with increasing research to adopt these tools in the field of dentistry, gastroenterology, and gynecology are factors influencing the market growth and adoption of optical imaging systems. However, high costs of instruments, stringent regulatory approval procedures, a dearth of skilled operators, and insufficient reimbursements for optical imaging procedures are factors posing several challenges to the overall growth of the market during the forecast period. The prominent players of global o

The global interventional cardiology devices market size is projected to reach USD 25.5 billion by 2027 from USD 17.5 billion in 2022, at a CAGR of 7.7%. Market growth is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, approval of new and advanced products, and the increasing prevalence of diabetes. High growth in emerging economies such as China, India, and Brazil are also driving the demand for interventional cardiology devices. However, the availability of alternative treatments and product failures and recalls are the major factors that are expected to restrain the growth of this market during the forecast period. The interventional cardiology devices market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascu

The global in vitro toxicology testing market size is projected to reach USD 18.6 billion by 2027 from USD 11.2 billion in 2022, growing at a CAGR of 10.8%. The primary growth factors such as increasing R&D expenditure to detect toxicity at an early stage during drug development drive the market. Also, the increasing focus of the pharmaceutical and cosmetics industries on using in vitro methods are expected to offer significant opportunities for market growth in the coming years. Thermo Fisher Scientific Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US) are some key players in this market. These companies are focusing

The precision medicine software market is projected to reach USD 2.0 billion by 2024 from USD 1.2 billion in 2019, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. Also, emerging markets, cloud-based solutions, and artificial intelligence in precision medicine may act as an important boosting factor for the exponential growth of the precision medicine software market. On the other hand, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and lack of skilled IT professionals in healthcare are the key factors that are expected to challenge market growth to a certain extent during the forecast period. The

The global eHealth market size is projected to reach USD 193.8 billion by 2025 from USD 69.5 billion in 2020, at a CAGR of 22.8% during the forecast period. Factors such as the increased adoption of eHealth solutions, rising elderly population base, and the growing number of infectious diseases are expected to drive the growth of the eHealth market. Players in the global eHealth industry include Cerner (US), McKesson (US), Philips Healthcare (Netherlands), GE Healthcare (US), and Allscripts (US). Other leading players in this market include athenahealth (US), Epic Systems (US), IBM (US), Optum (US), Siemens Healthineers (Germany), Medtronic (Ireland), and Cisco Systems (US).. These players are focusing on increasing their presence in high-growth markets through both organic as well as inorganic growth strategies, including service launches, expansions, collaborations, and partnerships. To know about the assumptions considered for the study download the pdf brochure: http

The global wearable healthcare devices market is projected to reach USD 30.1 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 13.2% during the forecast period. Growth in the wearable healthcare devices market is mainly driven by factors such as the development of technologically advanced products and growing geriatric population and subsequent increase in the incidence of chronic diseases. However, patent protection of wearable healthcare devices and limited battery life are the major factors hampering the growth of this market. The major players in this market are Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), GE Healthcare (US), Fitbit Inc. (US), Abbott Laboratories (US), OMRON Corporation (Japan), Garmin Ltd. (US), Dexcom Inc. (US), Masimo Corporation (US), Medtronic PLC (Ireland), BioTelemetry Inc. (US), Preventice Solutions Inc. (US), iRhythm Technologies Inc. (US), Contec Medical Systems Co. Ltd. (China), MediBioSense Ltd. (UK), VitalConnect (U

  The global medical device contract manufacturing market is projected to reach USD 118.9 billion in 2027 from USD 71.2 billion in 2022, at a CAGR of 10.8% during the forecast period. The key factors driving the growth of the medical device contract manufacturing market include technological advancements in medical device modalities and the impact of industry 4.0 on the medical device industry. On the other hand, consolidation of market players is set to impede the market growth. The Key players in the medical device contract manufacturing market include Jabil Inc. (US),  Plexus Corp. (US), Flex Ltd. (Singapore), Nipro Corporation (Japan), TE Connectivity Ltd. (Switzerland), Sanmina Corporation (US), and Integer Holdings Corporation (US). Jabil, Inc. Jabil, Inc. (US) is a leading player in the medical device contract manufacturing market. Its product portfolio includes a focused range of products and services in the healthcare domain as well as advanced manufacturing tech

The global laboratory information systems market is projected to reach USD 2.4 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 9.0% during the forecast period. A laboratory information system (LIS) is a software solution that handles the receiving, processing, and storage of information generated by laboratories. Growth in the LIS market can be primarily attributed to the rising prevalence of chronic diseases, the need for laboratory automation & increased lab efficiency, and the development of integrated LIS. The surge in demand for personalized medicine and the growing popularity of cloud-based LIS is expected to provide significant opportunities to the market players, especially in emerging economies. However, high maintenance and service costs, the requirement of specialized laboratory units, interfacing issues, and a dearth of skilled professionals are likely to challenge market growth in the coming years. Some of the prominent players operating in th

The global cancer biomarkers market is projected to reach USD 28.2 billion by 2026 from USD 12.4 billion in 2021, at a CAGR of 17.7% during the forecast period. Growth in the cancer biomarkers market is mainly driven by factors such as the increasing use of cancer biomarkers in drug discovery & development and increasing R&D on cancer biomarkers. However, patent protection of cancer biomarkers and limited battery life are the major factors hampering the growth of this market. The major players in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), bioMérieux SA (US), Becton, Dickinson and Company (US), Merck Millipore (US), Agilent Technologies (US), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), Hologic, Inc. (US), Quest Diagnostics (US), Centogene N.V. (Germany), PerkinElmer, Inc.; (US), Siemens Healthinee

The oral care market is projected to reach USD 54.9 billion by 2026 from USD 47.2 billion in 2021, at a CAGR of 3.1% during the forecast period. The rising incidence of dental diseases, the rising number of practicing dentists on a global scale, and technological advancements in oral care products are the major factors driving the growth of the oral care market. On the other hand, product recalls for the oral care market are expected to restrain the markets growth. Moreover, the adverse effects of teeth whitening products pose a major challenge to the growth of this market. The global oral hygiene market is fairly consolidated. Colgate-Palmolive Company (US), Procter & Gamble (US), GlaxoSmithKline plc (Ireland), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (US), Unilever plc (UK) are the major players in this market. These companies adopted strategies such as acquisitions, partnerships, agreements, collaborations, expansions, and product launches to

The global remote patient monitoring market is projected to reach USD 175.2 Billion by 2027 from USD 53.6 Billion in 2022, at a CAGR of 26.7% during the forecast period. The new research study provides the company evaluation quadrant for 25 companies operating in the remote patient monitoring market. The predominant factors influencing the growth of the market include the benefits of remote patient monitoring to reduce the burden on medical resources, the monitoring benefits of telehealth and remote patient monitoring services, advancements in telecommunications, an increasing geriatric population, and the growing need to expand healthcare access. However, the regulatory differences and challenges among various regions, combined with the informal usage of social media practises and related healthcare fraud, are some factors that are anticipated to negatively affect market growth during the forecast period. Prominent players in the market are Koninklijke Philips N.V. (Nethe

The global immunoassay market is projected to reach USD 49.6 billion by 2027 from USD 40.2 billion in 2022, at a CAGR of 4.3% during the forecast period. The immunoassay market is driven by the increasing incidence of chronic and infectious diseases, advancements in systems and technologies, and supportive government policies. The top players in this market are Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland) and Siemens Healthineers AG (Germany). These players lead the market because of their extensive product portfolios. These players have also invested in organic strategies such as product launches and regulatory approvals and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain their market shares. Get Customized Report By Competitive Landscape : https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=436 Abbott Laboratories (US) was the-largest player in 2021, with a share of 20–25%. Abbott h

A defibrillator is a device that monitors the heart rhythm and delivers electric shocks upon detecting an abnormal heart rhythm to restore the normal heart rhythm. The device plays an important role in the management and treatment of sudden cardiac arrest. Market growth is mainly driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs & CRT-Ds are expected to offer growth opportunities for players in the defibrillators market. The global defibrillator market is expected to reach USD 18.2 billion by 2026 from an estimated USD 11.4 billion in 2021, at a CAGR of 9.7% from 2021 to 2026. The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2018–2020 to expand their global presence and increase their market shares in the defibrilla